AzTrials
AzTrials

Healthy VolunteersNCT03223636

Measuring the Latency Connectome in the Central Nervous Systems Using Neuroimaging and Neurophysiological Techniques

An observational study of Healthy Volunteers, run by National Institute of Neurological Disorders and Stroke (NINDS) at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Background: Little is known about the time it takes for nerve signals to go from one area of the brain to another. Using advanced methods for brain research, researchers want to look at the time it takes to send messages between different brain areas. They also want to develop new tests. Read more about this study

Who is it for?
Ages 18 to 70 yearsHealthy volunteers can take part
Conditions the study is for
Healthy Volunteers
What is being tested?
TMS and MRI
Type of treatment
Medical device
How many people
16 participants
Where
1 siteUnited States
Study dates
2 Oct 2017to 26 Feb 2021
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 70 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: Healthy Volunteers

Who may be able to join

  • Ages between 18-70 years.
  • Right-handed (tested by the Edinburg handedness inventory).
  • Able to give informed consent and able to comply with all study procedures.

Who cannot join

  • Self-reported consumption of >14 alcoholic drinks/week for a man and >7 alcoholic drinks/week for a woman.
  • Abnormal findings on neurological examination.
  • History of brain tumor, stroke, head trauma with loss of consciousness, epilepsy or seizures.
  • Current episode of any major psychiatric illness.
  • Use of medications that act directly on the CNS.
  • Hearing loss reported in the history or detected in the routine physical examination
Show all 16Show fewer
  • Having permanent tattooed makeup (eyeliner, lip, etc.) or general tattoos. Subjects with tattoos will be excluded if those are in a dangerous location in the body or made with colors (e.g. dark blue and dark green) whose content in iron cannot be definitely ruled out by the investigators.
  • Having non-organic implant or any other device such as: cardiac pacemaker, insulin infusion pump, implanted drug infusion device, cochlear, otologic, or ear implant, transdermal medication patch, any metallic implants or objects, body piercing(s), bone/joint pin, screw, nail, plate, wire sutures or surgical staples, shunt.
  • Having cerebral or other aneurysm clips.
  • Having shrapnel or other metal imbedded in the body (such as from war wounds or accidents).
  • Had severe accidents in the past that may possibly have left metal in the body.
  • Previously worked in metal fields or with machines that may have left any metallic fragments in or near eyes.
  • Having any psychological contraindications for MRI (e.g., suffer from claustrophobia, unable to lie comfortably on your back for 2 hours).
  • Discomfort being in a small space for the expected length of the experiment, up to 2 hours.
  • Pregnancy.
  • NIH staff from HMCS in NINDS, Section on Quantitative Imaging and Tissue Sciences in NICHD or MEG Core facility in NIMH involved in the protocol.

Trial locations and contacts

1 site in 1 country.

United States1 site
  • National Institutes of Health Clinical Center

    Bethesda, Maryland, 20892

Other trials in United States

About this study

Official title: Measuring the Latency Connectome in the Central Nervous System Using Neuroimaging and Neurophysiological Techniques

Background:

Little is known about the time it takes for nerve signals to go from one area of the brain to another. Using advanced methods for brain research, researchers want to look at the time it takes to send messages between different brain areas. They also want to develop new tests.

Read more

Objectives:

To develop tests to measure the sizes of nerve fibers in the peripheral nerve system and in the brain. Also to find out the different speeds that information travels in nerve fibers.

Eligibility:

Healthy, right-handed people ages 18-70

Design:

Participants will be screened with medical history and a physical exam.

Participants will have up to 7 visits depending on the tests they choose. Visits last about 2-4 hours and may involve the following tests:

  • Physical exam
  • Urine tests
  • Magnetic resonance imaging (MRI). Participants lie on a table that slides into a scanner. They will be in the scanner for up to 1 hour. For some scans, sensors are placed on the skin. They will get earplugs for loud noises.
  • Small, sticky pads on the skin will electrically stimulate nerves in the forearm.
  • Transcranial magnetic stimulation (TMS). A wire coil will be held to the scalp. A brief electrical current passes through the coil to affect brain activity.
  • Electroencephalography. TMS will be given to the brain. Small electrodes on the scalp measure brain activity. Participants may do small tasks.
  • Electrodes on the scalp will send an electrical current to the brain.
  • A cone with magnetic detectors will be lowered onto the head to record brain activity. Participants will perform various tasks.
Read the detailed description

Objectives:

We are proposing the development and assessment of an MRI and neurophysiology-based experimental and theoretical framework to measure peripheral and intercortical latencies and latency distributions in the living human. This entails combining and integrating neurophysiological and neuroimaging so that we can eventually generate latency and latency distribution matrices for central nervous systems (CNS) using neuroimaging techniques. Neuroimaging and neurophysiological studies in the peripheral nerve system (PNS) will provide essential data for proof-of-concept and for validating this approach.

Study Population:

We intend to study up to 40 healthy volunteers. Each subject will complete 1 to 8 visits involving various measurements with different neuroimaging and neurophysiological techniques.

Design:

This is an exploratory study that consists of different measurements using multimodal neurophysiological and neuroimaging techniques. Diffusion magnetic resonance imaging (MRI), mean apparent propagator (MAP)-MRI, AxCaliber MRI, multiple pulsed field gradient MRI, and resting-state functional MRI will be performed in 1 to 2 visits. In another 1 to 5 visits, we will use neurophysiological techniques including peripheral electrical stimulation, transcranial magnetic stimulation (TMS), electroencephalography (EEG) and magnetoencephalography (MEG) with various experimental paradigms to correlate with the latency and latency distribution matrices generated by neuroimaging techniques. All these techniques are exploratory and success or failure of one of them does not have immediate implications for the others.

Outcome Measures:

We will measure average axon diameter (AAD) and axon diameter distributions (ADD), as well as compute white matter pathway trajectories using diffusion MRI and MAP-MRI data, and use resting-state functional MRI to measure blood oxygenation level-dependent signal to identify salient cortical regions in which many of these tracts terminate. For proof-of-concept measurements in the PNS, compound muscle action potential or surface compound nerve action potential on the skin will be measured following peripheral nerve stimulation. For TMS , we will measure motor evoked potential (MEP) amplitude. Cortical evoked potential in different cortical areas induced by TMS will be measured in EEG recordings. We will study millisecond coupling delays between different cortical areas with MEG. We will measure time and phase delays as computed from whole-head signals in the subject. Coherence analysis for cortical activity with EEG and MEG recordings between different cortical areas will be performed. We will attempt to correlate MRI measurements with the individual physiological measurements.

Being tested
TMS, MRI
Keywords
Transcranial Magnetic Stimulation (TMS), Magnetic Resonance Imaging (MRI), Electroencephalogram (EEG), Magnetoencephalogram, Transcranial Electrical Stimulation (TES)

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • TMSDevice

    We will use TMS with paired-pulse technique to activate corticospinal neurons in the primary motor cortex and motorneurons in the brainstem, respectively (Hallett 2007; Ugawa et al. 1991; Ugawa et al.1994). Two stimulations will be separated with various interstimulus intervals to produce collision on nerve fibers with different conduction velocity in the corticospinal tract. The conduction time on nerve fibers in the corticospinal tract with different conduction velocity will be identified and the distribution of these fibers will be calculated.

  • MRIDevice

    MRI exams will consist of several sessions including calibration, anatomic, and diffusion MRI scanning (Avram et al. 2013; Avram et al. 2016; Pierpaoli et al. 1996). Data in each exam will be acquired in the left or right forearm (PNS).

Study groups in NCT03223636
Study groupRoleWhat they receive
Healthy VolunteersHealthy Volunteers
Receives: Device: TMS; Device: MRI

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. measure motor evoked potential (MEP) amplitude

    For TMS, we will measure motor evoked potential (MEP) amplitude

    Measured: throughout

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Jul 2017
  2. Study start2 Oct 2017
  3. Primary completion12 Nov 2020
  4. Study completion26 Feb 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case only
Time perspective
Cross-sectional
Enrolment
16 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03223636
Sponsor's protocol ID
170128
Other IDs
17-N-0128
Status last verified
Mar 2021
First submitted
19 Jul 2017
Last updated
30 Apr 2021
Results posted
No
FDA-regulated drug
No
FDA-regulated device
Yes

Publications

  • Ni Z, Leodori G, Vial F, Zhang Y, Avram AV, Pajevic S, Basser PJ, Hallett M. Measuring latency distribution of transcallosal fibers using transcranial magnetic stimulation. Brain Stimul. 2020 Sep-Oct;13(5):1453-1460. doi: 10.1016/j.brs.2020.08.004. Epub 2020 Aug 11.

    PubMed 32791313

Questions about this trial

What is this clinical trial studying?

An observational study of Healthy Volunteers, run by National Institute of Neurological Disorders and Stroke (NINDS) at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 16 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 30 Apr 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

measure motor evoked potential (MEP) amplitude (time frame: throughout). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03223636, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Apr 2021.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in
Clinical Trial NCT03223636 | AzTrials